sandoz
ActiveDirectors
Directors
2 directors, no change since 2026
Board 2
Dries Pattyn
Current
Director · since 29-06-2023 · 6-year term from 2023 · also on the board of 2 other companies · listed in the 2025 annual accounts, filed on 15-07-2026
Ankit Agarwal
Current
Director · since 11-02-2026 · 6-year term from 2026 · listed in the 2025 annual accounts, filed on 15-07-2026
Statutory auditor 1
KPMG Bedrijfsrevisoren
Current
Statutory auditor · current term since 03-06-2025 · permanent representative: Steven Veyt · listed in the 2025 annual accounts, filed on 15-07-2026
Owners and capital
Shareholders
1 ownerChain of control
- Sandoz AGCH
- sandoz
Owners 1
- Sandoz AGCHparentSourceown accounts 2025100%
Capital transactions
Shareholders according to the deeds
Share transfer
act of 24-03-2023 ↗
- Novartis Pharma NV to SANDOZ
- Novartis Pharma NV to SANDOZ
Capital over time
- 03-06-2020 Capital stated in the deed · €19,240,000 · 776,129 shares
Mandate history
40 people, 3 in office
- Board
- Day-to-day management
- Statutory auditor
- Other function
- began earlier
- end not dated
| Name | Functions and periods |
|---|---|
| Dries Pattyn |
|
| Ankit Agarwal |
|
| KPMG Bedrijfsrevisoren |
|
| Rodrigo Osorio Aguilar |
|
| Anatoliy Ivanov |
|
| Christophe Delenta |
|
| Andrea Majocchi |
|
| Federico Mambretti |
|
| Bruno Barcelos |
|
| PricewaterhouseCoopers Reviseurs d'Entreprises |
|
| Guy Oliver |
|
| Nicolas Thiriet |
|
| Andrej Pardo |
|
| Knut Magerl |
|
| Rebecca Guntern Flückiger |
|
| Dario Drago |
|
| Marco Pucci |
|
| Aude Vileyn |
|
| Diedert Geysen |
|
| Nicolas Steylemans |
|
| Inge De Vuyst |
|
| Jens-Peter Thiede |
|
| Dirk Grauwels |
|
| Johan Deberlanger |
|
| Rebecca Guntern |
|
| Vincent Verschraegen |
|
| Knut Mager Webb |
|
| Nancy Vander Linden |
|
| Knut Mager |
|
| Nicholas Haggar |
|
| Sue Webb |
|
| Dominique Petit |
|
| Dubos |
|
| Frederic Rodrigues Simoes |
|
| Jean-Claude Dubos |
|
| Romain Légé |
|
| Bertrand Bugnon |
|
| Andreas Strüngmann |
|
| Siegfried Leitner |
|
| Eric Gorka |
|